Variant report
Variant | nsv1050859 |
---|---|
Chromosome Location | chr13:66097803-66140439 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140703519 | chr13:66102424-66102425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369791866 | chr13:66102488-66102489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373509141 | chr13:66102512-66102513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551963994 | chr13:66102517-66102518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554119236 | chr13:66102568-66102569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570784363 | chr13:66102571-66102572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143778956 | chr13:66102610-66102611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556590233 | chr13:66102750-66102751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568753551 | chr13:66102775-66102776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542440064 | chr13:66102783-66102784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147219376 | chr13:66102784-66102785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574572211 | chr13:66102790-66102791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539983769 | chr13:66102796-66102797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560067827 | chr13:66102799-66102800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533881674 | chr13:66102821-66102822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568533127 | chr13:66102849-66102850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs78908103 | chr13:66102868-66102869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs180957838 | chr13:66102954-66102955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11148683 | chr13:66102973-66102974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567947958 | chr13:66102985-66102986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73514611 | chr13:66102997-66102998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs142173485 | chr13:66103026-66103027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547739381 | chr13:66103047-66103048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570785510 | chr13:66103052-66103053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34826860 | chr13:66103075-66103076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186295556 | chr13:66103085-66103086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112472336 | chr13:66103093-66103094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs8000508 | chr13:66103107-66103108 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs4883757 | chr13:66103122-66103123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75513461 | chr13:66103210-66103211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139113409 | chr13:66103215-66103216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540291480 | chr13:66103288-66103289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558622202 | chr13:66103304-66103305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368659232 | chr13:66103309-66103310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114070017 | chr13:66103401-66103402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576723917 | chr13:66103434-66103435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545477925 | chr13:66103441-66103442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537747139 | chr13:66103443-66103444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71442668 | chr13:66103482-66103483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370852327 | chr13:66103489-66103490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115050392 | chr13:66103497-66103498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34355253 | chr13:66103500-66103501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548107622 | chr13:66103531-66103532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561516563 | chr13:66103548-66103549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189508287 | chr13:66103565-66103566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547823595 | chr13:66103569-66103570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111822630 | chr13:66103597-66103598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34114804 | chr13:66103631-66103632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549893381 | chr13:66103641-66103642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200401793 | chr13:66103649-66103650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Intellectual disability | 21811512 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 20877625 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66102400-66103200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr13:66102600-66104600 | Enhancers | Fetal Lung | lung |
3 | chr13:66102800-66103200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:66102800-66103200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr13:66104200-66107400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr13:66104400-66105600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr13:66104800-66105000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr13:66113800-66114800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr13:66113800-66115000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr13:66114200-66114400 | Active TSS | A549 | lung |
11 | chr13:66114200-66114800 | Enhancers | NH-A | brain |
12 | chr13:66114400-66114600 | Flanking Active TSS | A549 | lung |
13 | chr13:66114600-66114800 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr13:66114800-66115000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr13:66114800-66115000 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr13:66116000-66116400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr13:66127000-66127800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr13:66127400-66127800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr13:66129800-66130200 | Enhancers | Brain Germinal Matrix | brain |
20 | chr13:66130000-66130600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
21 | chr13:66130000-66130600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
22 | chr13:66130200-66131000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
23 | chr13:66130600-66131600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
24 | chr13:66131600-66131800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |